Heart Drugs Found Ineffective in Treating Pulmonary Hypertension
MAY 19, 2011
As reported in HealthDay, a U.S. National Institutes of Health-funded study found that aspirin and simvastatin provide no benefit to those experiencing pulmonary arterial hypertension. "The results of this study do not support the routine treatment of PAH with these medications," said Steven Kawut, MD, MS, associate professor of Medicine and Epidemiology and lead author of the study. "The findings show the importance of subjecting traditional cardiovascular therapies and drugs which appear effective in the laboratory to placebo-controlled [randomized clinical trials] in humans before recommending their use." Coverage also appeared in Internal Medicine News.
